CAP70 suppresses the development of triple-negative breast cancer by inhibiting EGFR pathway activation

被引：0
|
作者：
Zheng, Junfang [1 ]
Ma, Yuanzhen [1 ]
Qi, Yijun [1 ]
机构：
[1] Capital Med Univ, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5981
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5981
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
    Qi, Yufeng
    Wu, Haodong
    Zhu, Tianru
    Liu, Zitian
    Liu, Conghui
    Yan, Congzhi
    Wu, Zhixuan
    Xu, Yiying
    Bai, Ying
    Yang, Lehe
    Cheng, Dezhi
    Zhang, Xiaohua
    Zhao, Haiyang
    Zhao, Chengguang
    Dai, Xuanxuan
    AGING-US, 2023, 15 (16): : 8258 - 8274
  • [2] Albendazole ameliorates triple-negative breast cancer by inhibiting glucose uptake pathway
    Liu, Honglian
    Sun, Hao
    Zhang, Bin
    Liu, Shengli
    Deng, Shengming
    Weng, Zhen
    Zuo, Bin
    Yang, Jianfeng
    He, Yang
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S578 - S579
  • [3] Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
    Shen, Minhong
    Jiang, Yi-Zhou
    Wei, Yong
    Ell, Brian
    Sheng, Xinlei
    Esposito, Mark
    Kang, Jooeun
    Hang, Xiang
    Zheng, Hanqiu
    Rowicki, Michelle
    Zhang, Lanjing
    Shih, Weichung J.
    Celia-Terrassa, Toni
    Liu, Yirong
    Cristea, Ileana
    Shao, Zhi-Ming
    Kang, Yibin
    CANCER CELL, 2019, 35 (01) : 64 - +
  • [4] SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
    Choi, Yu-Jeong
    Lee, Kangwook
    Yoon, Ji-Hye
    Cho, Sung-Gook
    Kim, Yun-Gyeong
    Jeong, Miso
    Hwang, Hyun-Ha
    Lee, Seo Yeon
    Jung, Se-Eun
    Ko, Seong-Gyu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] The hedgehog pathway in triple-negative breast cancer
    Habib, Joyce G.
    O'Shaughnessy, Joyce A.
    CANCER MEDICINE, 2016, 5 (10): : 2989 - 3006
  • [6] Role of flavonoids in inhibiting triple-negative breast cancer
    Wang, Shuai
    Wang, Kuanyu
    Li, Cheng
    Chen, Jing
    Kong, Xiangding
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] FOXO4 suppresses cisplatin resistance of triple-negative breast cancer by inhibiting autophagy
    Zhu, Yating
    Zhang, Chenguang
    Yin, Qiuyu
    Xu, Wenting
    Luo, Yulou
    Ou, Jianghua
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369 (02): : 252 - 263
  • [8] cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
    Sohn, Joohyuk
    Liu, Shuying
    Parinyanitikul, Napa
    Lee, Jangsoon
    Hortobagyi, Gabriel N.
    Mills, Gordon B.
    Ueno, Naoto T.
    Gonzalez-Angulo, Ana M.
    JOURNAL OF CANCER, 2014, 5 (09): : 745 - 753
  • [9] As4O6 suppresses triple-negative breast cancer via inhibiting EGFR/mTOR mediated EMT in vitro and in vivo
    Bae, Illju
    Lian, Zenglin
    Liu, Ziyao
    Wu, Zhaoyan
    CANCER RESEARCH, 2019, 79 (13)
  • [10] LGR4 attenuates MGP expression and suppresses EGFR activation-induced triple-negative breast cancer metastasis
    Li, Qishuang
    Gao, Yankun
    Huo, Zitian
    Liu, Jing
    Zhang, Pumin
    Wang, Yi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07):
12345